SEC Form 4 · accession 0001209191-19-010827
Phio Pharmaceuticals Corp. · PHIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
H. Paul Dorman
Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 9:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001533040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Feb 13, 2019 | A | 10,000 | $0.00 | A | 20,375 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares underlying a restricted stock unit, which shares will vest in one installment on the first anniversary of the grant date.